{"address1": "10628 Science Center Drive", "address2": "Suite 250", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 900 2660", "website": "https://arcturusrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Arcturus Therapeutics Holdings Inc. engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms includes LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate that is in phase 2 clinical trial for cystic fibrosis. Its product pipeline includes KOSTAIVE for the treatment of covid 19; ARCT-2138 (LUNAR-FLU), which is in phase 1 clinical trial for the treatment of seasonal influenza; ARCT-2304 (LUNAR-H5N1) that is in phase 1 clinical trial for the treatment of Pandemic Influenza; ARCT-2301 for bivalent: ancestral/omicron which is in Phase 3 clinical trial; and ARCT-2303 for monovalent that is in Phase 3 clinical trial. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.", "fullTimeEmployees": 174, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joseph E. Payne M.Sc.", "age": 52, "title": "Founder, President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 906500, "exercisedValue": 0, "unexercisedValue": 5381721}, {"maxAge": 1, "name": "Dr. Padmanabh  Chivukula Ph.D.", "age": 45, "title": "Founder, Chief Scientific Officer, COO & Secretary", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 687500, "exercisedValue": 0, "unexercisedValue": 4401638}, {"maxAge": 1, "name": "Mr. Andrew H. Sassine MBA", "age": 60, "title": "CFO & Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 687500, "exercisedValue": 0, "unexercisedValue": 5663780}, {"maxAge": 1, "name": "Mr. Lance  Kurata", "title": "Chief Legal Officer", "fiscalYear": 2023, "totalPay": 600000, "exercisedValue": 0, "unexercisedValue": 456563}, {"maxAge": 1, "name": "Ms. Neda  Safarzadeh", "title": "Vice President and Head of IR/PR & Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Natasha O. Bowman", "title": "Chief Human Resources Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin T. Skol", "title": "Chief Business Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Juergen  Froehlich FCPh, M.D., MBA", "age": 68, "title": "Chief Medical Officer", "yearBorn": 1956, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Igor  Smolenov M.D., Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Roberta  Duncan", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 3, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 6, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.59, "open": 10.49, "dayLow": 9.41, "dayHigh": 10.49, "regularMarketPreviousClose": 10.59, "regularMarketOpen": 10.49, "regularMarketDayLow": 9.41, "regularMarketDayHigh": 10.49, "payoutRatio": 0.0, "beta": 2.964, "forwardPE": -4.2286997, "volume": 884289, "regularMarketVolume": 884289, "averageVolume": 422541, "averageVolume10days": 411580, "averageDailyVolume10Day": 411580, "bid": 7.44, "ask": 12.08, "bidSize": 1, "askSize": 1, "marketCap": 255739728, "fiftyTwoWeekLow": 9.41, "fiftyTwoWeekHigh": 45.0, "priceToSalesTrailing12Months": 1.6790738, "fiftyDayAverage": 15.3104, "twoHundredDayAverage": 19.16685, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 47261932, "profitMargins": -0.53142, "floatShares": 24833622, "sharesOutstanding": 27119800, "sharesShort": 4410136, "sharesShortPriorMonth": 4228550, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1626, "heldPercentInsiders": 0.08448, "heldPercentInstitutions": 0.92542, "shortRatio": 9.61, "shortPercentOfFloat": 0.2548, "impliedSharesOutstanding": 27119800, "bookValue": 8.893, "priceToBook": 1.0603846, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -80941000, "trailingEps": -3.0, "forwardEps": -2.23, "lastSplitFactor": "1:7", "lastSplitDate": 1510790400, "enterpriseToRevenue": 0.31, "enterpriseToEbitda": -0.513, "52WeekChange": -0.71197313, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 9.43, "targetHighPrice": 140.0, "targetLowPrice": 44.0, "targetMeanPrice": 73.101, "targetMedianPrice": 66.5, "recommendationMean": 1.3, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 10, "totalCash": 237028000, "totalCashPerShare": 8.74, "ebitda": -92125000, "totalDebt": 28550000, "quickRatio": 3.68, "currentRatio": 4.672, "totalRevenue": 152310000, "debtToEquity": 11.848, "revenuePerShare": 5.641, "returnOnAssets": -0.15461001, "returnOnEquity": -0.31162, "grossProfits": -42846000, "freeCashflow": -9018125, "operatingCashflow": -59747000, "revenueGrowth": -0.262, "grossMargins": -0.28131, "ebitdaMargins": -0.60485, "operatingMargins": -1.46684, "financialCurrency": "USD", "symbol": "ARCT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Arcturus Therapeutics Holdings Inc.", "shortName": "Arcturus Therapeutics Holdings ", "regularMarketChangePercent": -10.953728, "regularMarketPrice": 9.43, "marketState": "PRE", "preMarketPrice": 8.91, "regularMarketChange": -1.1599998, "regularMarketDayRange": "9.41 - 10.49", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 422541, "fiftyTwoWeekLowChange": 0.020000458, "fiftyTwoWeekLowChangePercent": 0.0021254472, "fiftyTwoWeekRange": "9.41 - 45.0", "fiftyTwoWeekHighChange": -35.57, "fiftyTwoWeekHighChangePercent": -0.79044443, "fiftyTwoWeekChangePercent": -71.19731, "dividendDate": 1510790400, "earningsTimestamp": 1741294860, "earningsTimestampStart": 1746529140, "earningsTimestampEnd": 1747051200, "earningsCallTimestampStart": 1741296600, "earningsCallTimestampEnd": 1741296600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.0, "epsForward": -2.23, "epsCurrentYear": -4.78133, "priceEpsCurrentYear": -1.9722546, "fiftyDayAverageChange": -5.8803997, "fiftyDayAverageChangePercent": -0.38407877, "twoHundredDayAverageChange": -9.736849, "twoHundredDayAverageChangePercent": -0.50800467, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1369229400000, "preMarketChange": -0.52000046, "preMarketChangePercent": -5.514321, "corporateActions": [], "preMarketTime": 1743581915, "regularMarketTime": 1743537601, "exchange": "NGM", "messageBoardId": "finmb_235062181", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Arcturus Therapeutics", "trailingPegRatio": null}